TEVA PHARMACEUTICAL-SP ADR (TEVA) Stock Institutional Trading Activity


TEVA PHARMACEUTICAL-SP ADR (TEVA) position changes reported by tracked institutional filers across multiple SEC 13F reporting periods. Based on recent SEC 13F filings (Q3 2025), investors with some of the largest reported share count changes include Viking Global Investors, Renaissance Technologies LLC, Sound Shore Management, Sequoia Financial Advisors, and ARK Invest. Explore insights into buying and selling patterns, position changes, and investment conviction levels to understand institutional trading behavior and market dynamics.

Explore more:

Portfolio quarterNameTypeQuantityRemainingReported stock balance
Q3 2025Sequoia Financial AdvisorsBuy2,655135,948$2,746,154
Q3 2025Renaissance Technologies LLCSell-2,154,4371,002,545$20,251,409
Q3 2025Viking Global InvestorsSell-9,149,2142,532,119$51,148,804
Q3 2025Sound Shore ManagementSell-199,0635,647,449$114,078,470
Q3 2025ARK InvestSell-2,153118,721$2,398,164
Q2 2025Sequoia Financial AdvisorsBuy541133,293$2,233,991
Q2 2025Renaissance Technologies LLCSell-2,144,2633,156,982$52,911,018
Q2 2025Viking Global InvestorsBuy1,555,85511,681,333$195,779,141
Q2 2025Sound Shore ManagementBuy394,4235,846,512$97,987,541
Q2 2025ARK InvestBuy30,621120,874$2,025,848
Q1 2025Sequoia Financial AdvisorsBuy18,955132,752$2,040,396
Q1 2025Renaissance Technologies LLCSell-1,674,9735,301,245$81,480,136
Q1 2025Viking Global InvestorsBuy3,621,99310,125,478$155,628,597
Q1 2025ARK InvestSell-10,19090,253$1,387,189
Q1 2025Sound Shore ManagementBuy679,3775,452,089$83,798,608
Q4 2024Sequoia Financial AdvisorsBuy1,417113,797$2,508,086
Q4 2024Viking Global InvestorsSell-1,064,0486,503,485$143,336,809
Q4 2024Renaissance Technologies LLCSell-1,136,7456,976,218$153,755,845
Q4 2024ARK InvestSell-23,422100,443$2,213,764
Q4 2024Sound Shore ManagementSell-1,204,1324,772,712$105,190,573
Q3 2024Sequoia Financial AdvisorsBuy805112,380$2,025,088
Q3 2024Viking Global InvestorsSell-12,116,6867,567,533$136,366,945
Q3 2024Renaissance Technologies LLCSell-615,6008,112,963$146,195,593
Q3 2024Sound Shore ManagementSell-784,6025,976,844$107,702,728
Q3 2024ARK InvestSell-45,555123,865$2,232,047
Q2 2024Miller Value PartnersSell-65010,950$177,937
Q2 2024Sequoia Financial AdvisorsBuy826111,575$1,813,094
Q2 2024Renaissance Technologies LLCBuy1,031,4008,728,563$141,839,149
Q2 2024ARK InvestSell-22,716169,420$2,753,075
Q2 2024Sound Shore ManagementSell-733,2446,761,446$109,873,498

Frequently asked questions about TEVA activity

  • Which institutional owners are buying TEVA?

    Institutional owners buying TEVA include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.

  • What does "buy" mean in TEVA activity?

    "Buy" means an investor increased their reported position in TEVA compared to the prior reporting period. This reflects growing exposure to TEVA PHARMACEUTICAL-SP ADR (TEVA) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).

  • Is institutional interest in TEVA increasing?

    Institutional interest in TEVA can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.